Hydrochloric Acid

Hydrochloric Acid

SCHEMBL17802252

CC(C)CNCc1cc(=O)n2cccc(O)c2n1.[Cl-].[H+]

nearest known ligand 0.51

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.51
KDM4E B2RXH2 1/20 0.51
ALDH1A1 P00352 1/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
MPI P34949 1/20 0.51
METTL3 Q86U44 3/20 0.41
POLB P06746 2/20 0.40
METTL14 Q9HCE5 1/20 0.38
MAPT P10636 1/20 0.37
PKM P14618 1/20 0.36
RXFP1 Q9HBX9 2/20 0.36
PRKDC P78527 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17808816 0.98 LMNA (0.53) LMNAKDM4EALDH1A1GLAGAA
Hydrochloric Acid SCHEMBL17802253 0.96 LMNA (0.55) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL19361114 0.85 LMNA (0.58) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808813 0.82 KDM4E (0.54) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL2901489 0.81 KDM4E (0.59) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808862 0.80 KDM4E (0.55) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808867 0.80 KDM4E (0.49) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808871 0.80 KDM4E (0.51) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808866 0.79 KDM4E (0.54) LMNAKDM4EALDH1A1GLAGAA
SCHEMBL17808875 0.79 LMNA (0.54) LMNAKDM4EALDH1A1GLAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227292-B1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS ALTERITY THERAPEUTICS LTD (AU) 2022-03-09 EP disclosed
US-20210230159-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2021-07-29 US disclosed
US-11008319-B2 4H-pyrido[1,2-a]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2021-05-18 US disclosed
US-20200317670-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2020-10-08 US disclosed
US-10738050-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2020-08-11 US disclosed
US-20190352301-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2019-11-21 US disclosed
US-10287285-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2019-05-14 US disclosed
EP-3227292-A1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS Prana Biotechnology Ltd (AU) 2017-10-11 EP disclosed
US-20170267676-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2017-09-21 US disclosed
WO-2016086261-A1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2016-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738050-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-20200317670-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-10287285-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-11008319-B2 4H-pyrido[1,2-a]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-20190352301-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-20210230159-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885
US-20170267676-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO LMNA 1246/4885KDM4E 2827/4885ALDH1A1 299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.